Page last updated: 2024-09-02

npc 12626 and u-50488

npc 12626 has been researched along with u-50488 in 1 studies

Compound Research Comparison

Studies
(npc 12626)
Trials
(npc 12626)
Recent Studies (post-2010)
(npc 12626)
Studies
(u-50488)
Trials
(u-50488)
Recent Studies (post-2010) (u-50488)
55001,6643209

Protein Interaction Comparison

ProteinTaxonomynpc 12626 (IC50)u-50488 (IC50)
Delta-type opioid receptorRattus norvegicus (Norway rat)2.15
Kappa-type opioid receptorMus musculus (house mouse)0.0027
Mu-type opioid receptorRattus norvegicus (Norway rat)2.15
Kappa-type opioid receptorRattus norvegicus (Norway rat)0.7171
Kappa-type opioid receptorCavia porcellus (domestic guinea pig)0.0958
Kappa-type opioid receptorHomo sapiens (human)0.0537

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ferkany, J; Kolesnikov, YA; Pasternak, GW1

Other Studies

1 other study(ies) available for npc 12626 and u-50488

ArticleYear
Blockade of mu and kappa 1 opioid analgesic tolerance by NPC17742, a novel NMDA antagonist.
    Life sciences, 1993, Volume: 53, Issue:19

    Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Amino Acids; Analgesics; Animals; Drug Tolerance; Mice; Mice, Inbred Strains; Morphine; N-Methylaspartate; Pyrrolidines; Receptors, Opioid, kappa; Receptors, Opioid, mu

1993